The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Mycosis Fungoides: Disease Evolution and Prognosis of 309 Dutch Patients
Abstract
OBJECTIVES: To determine the disease course of Dutch patients with mycosis fungoides and to define factors related to disease progression and survival. DESIGN: A multicenter, 13-year, retrospective cohort analysis. SETTING: Eight dermatology departments collaborating in the Dutch Cutaneous Lymphoma Group. PATIENTS: Three hundred nine patients with mycosis fungoides registered between October 1985 and May 1997, including 89 patients with limited patches or plaques (stage Ia), 135 with generalized patches or plaques (stage Ib), 46 with skin tumors (stage Ic), 18 with enlarged but uninvolved lymph nodes (stage II), 18 with lymph node involvement (stage III), and 3 with visceral involvement (stage IV). MAIN OUTCOME MEASURES: Response to initial treatment, sustained complete remission, actuarial disease progression, and overall and disease-specific survival per clinical stage. RESULTS: The median follow-up was 62 months (range, 1-113 months). For the entire group, the actuarial overall and disease-specific survival was 80% and 89% at 5 years, and 57% and 75% at 10 years, respectively. The actuarial 5-year disease-specific survival of patients with stage Ia, Ib, and Ic disease was 100%, 96%, and 80%, respectively, and only 40% for patients with stage III disease. Using multivariate analysis, the presence of extracutaneous disease, the type and extent of skin involvement, the response to initial treatment, and the presence of follicular mucinosis were independently associated with higher disease progression and mortality rates. The calculated risks of disease progression at 5 and 10 years gradually increased from 4% to 10% for those with stage Ia disease, from 21% to 39% for those with stage Ib disease, and from 32% to 60% for those with stage Ic disease; for those with stage III disease, the risk remained at 70% at 5 and 10 years. The overall risk of disease progression at 5 and 10 years was 24% and 38%, respectively, for the total study group. CONCLUSION: At least within the first 10 years after diagnosis, disease progression and mycosis fungoides-related mortality occur in only a subset of patients generally presenting with advanced disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
(2008) · The Concise Encyclopedia of Statistics · doi:10.1007/978-0-387-32833-1_5 · Cited by 2,670
Multiclass cancer diagnosis using tumor gene expression signatures
Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.-H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211566398 · Cited by 2,023
Willemze, R., Kerl, H., Sterry, W., Berti, E., Cerroni, L., Chimenti, M. S., Díaz-Pérez, J. L., Geerts, M., Goos, M., Knobler, R., et al. (1997) · PubMed · doi:10.1182/blood.v90.1.354 · Cited by 1,270
Self-citationWong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H.-L., Steinman, R. M., & Choi, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2075 · Cited by 853
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K.-M., Johnson, M., Lynch, D., Tsien, R. Y., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2354 · Cited by 662
Multiple roles of eph receptors and ephrins in neural development
Wilkinson, D. G. (2001) · Nature Reviews Neuroscience · doi:10.1038/35058515 · Cited by 610
T Cell-Specific Loss of Pten Leads to Defects in Central and Peripheral Tolerance
Suzuki, A., Yamaguchi, M. T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., Yoshida, R., Wakeham, A., Higuchi, T., Fukumoto, M., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00134-0 · Cited by 589
Nakamura, N., Ramaswamy, S., Vazquez, F., Signoretti, S., Loda, M., & Sellers, W. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8969-8982.2000 · Cited by 570
twist is a potential oncogene that inhibits apoptosis
Maestro, R., Tos, A. P. D., Hamamori, Y., Krasnokutsky, S., Sartorelli, V., Kedes, L., Doglioni, C., Beach, D. H., & Hannon, G. J. (1999) · Genes & Development · doi:10.1101/gad.13.17.2207 · Cited by 516
Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma
Hideshima, T., Nakamura, N., Chauhan, D., & Anderson, K. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204833 · Cited by 478
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Zelinski, D. P., Zantek, N. D., Stewart, J. C., Irizarry, A. R., & Kinch, M. S. (2001) · PubMed · Cited by 463
Weiss, L. M., Hu, E., Wood, G. S., Moulds, C., Cleary, M. L., Warnke, R., & Sklar, J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508293130903 · Cited by 339
Grønbæk, K., Straten, P. T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M. K., Hansen, N. E., Zeuthen, J., Hou-Jensen, K., & Guldberg, P. (1998) · Blood · doi:10.1182/blood.v92.9.3018 · Cited by 336
Josien, R., Li, H.-L., Ingulli, E., Sarma, S., R.Wong, B., Vologodskaia, M., Steinman, R. M., & Choi, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.495 · Cited by 334
The BCL11 gene family: involvement of BCL11A in lymphoid malignancies
Satterwhite, E., Sonoki, T., Willis, T. G., Harder, L., Nowak, R., Arriola, E. L., Liu, H., Price, H. P., Gesk, S., Steinemann, D., et al. (2001) · Blood · doi:10.1182/blood.v98.12.3413 · Cited by 314
Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients
Zackheim, H. S., Amin, S., Kashani-Sabet, M., & McMillan, A. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70491-3 · Cited by 294
Mycosis Fungoides in the United States: Increasing Incidence and Descriptive Epidemiology
Weinstock, M. A. (1988) · JAMA · doi:10.1001/jama.1988.03410010050033 · Cited by 285
The Apoptosis-Promoting Factor TIA-1 Is a Regulator of Alternative Pre-mRNA Splicing
Förch, P., Puig, O., Kedersha, N., Martínez, C., Granneman, S., Séraphin, B., Anderson, P., & Valcárcel, J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00107-6 · Cited by 284
Overexpression of the EphA2 tyrosine kinase in prostate cancer
Walker-Daniels, J., Coffman, K., Azimi, M., Rhim, J. S., Bostwick, D. G., Snyder, P., Kerns, B. J., Waters, D. J., & Kinch, M. S. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19991201)41:4<275::aid-pros8>3.0.co;2-t · Cited by 269
Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sézary Syndrome
Sausville, E. A., Eddy, J. L., Makuch, R. W., Fischmann, A. B., Schechter, G. P., Matthews, M., GLATSTEIN, E. J., Ihde, D. C., Kaye, F., Veach, S. R., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-372 · Cited by 268
Lindberg, R. A., & Hunter, T. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6316 · Cited by 257
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells
Bernengo, M. G., Novelli, M., Quaglino, P., Lisa, F., De Matteis, A., Savoia, P., Cappello, N., & Fierro, M. T. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04014.x · Cited by 201
Signaling by the TNF Receptor Superfamily and T Cell Homeostasis
Chan, F. K.-M., Siegel, R. M., & Lenardo, M. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)00041-8 · Cited by 200
Kim, Y. H., Chow, S., Varghese, A., & Hoppe, R. T. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.1.26 · Cited by 172
Cascino, I., Papoff, G., De Maria, R., Testi, R., & Ruberti, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.13 · Cited by 169
Dummer, R., Heald, P., Nestle, F., Ludwig, E., Laine, E., Hemmi, S., & Burg, G. (1996) · Blood · doi:10.1182/blood.v88.4.1383.bloodjournal8841383 · Cited by 169
The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
Vaishnaw, A. K., Orlinick, J. R., Chu, J., Krammer, P. H., Chao, M. V., & Elkon, K. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5121 · Cited by 154
Alternative Splicing and Programmed Cell Death
Jiang, Z., & Wu, J. Y. (1999) · Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-11.x · Cited by 145
Light-Microscopic Assessment of 100 Patients with Patch/Plaque-Stage Mycosis Fungoides
Nickoloff, B. J. (1988) · American Journal of Dermatopathology · doi:10.1097/00000372-198812000-00001 · Cited by 142
CD4+ cutaneous T-cell lymphoma cells express the p140–killer cell immunoglobulin-like receptor
Bagot, M., Moretta, A., Sivori, S., Biassoni, R., Cantoni, C., Bottino, C., Boumsell, L., & Bensussan, A. (2001) · Blood · doi:10.1182/blood.v97.5.1388 · Cited by 131
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma
Brender, C., Nielsen, M., Kaltoft, K., Mikkelsen, G., Zhang, Q., Wasik, M., Billestrup, N., & Ødum, N. (2001) · Blood · doi:10.1182/blood.v97.4.1056 · Cited by 129
Mycosis fungoides and the Sézary syndrome: Pathology, staging, and treatment
Hoppe, R. T., Wood, G. S., & Abel, E. (1990) · Current Problems in Cancer · doi:10.1016/0147-0272(90)90018-l · Cited by 125
Izban, K. F., Ergin, M., Qin, J. Z., Martinez, R. L., RJ, J. R. P., Saeed, S., & Alkan, S. (2000) · Human Pathology · doi:10.1053/hupa.2000.20370 · Cited by 123
Cloning of the human twist gene: Its expression is retained in adult mesodermally-derived tissues
Wang, S. M., Coljee, V. W., Pignolo, R. J., Rotenberg, M. O., Cristofalo, V. J., & Sierra, F. (1997) · Gene · doi:10.1016/s0378-1119(96)00727-5 · Cited by 119
Baer, R. J. (1993) · PubMed · Cited by 116
The Immunopemthogenesis of Cutaneous T-cell Lymphoma
Rook, A. H., & HEALD, P. W. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30054-6 · Cited by 106
AMY‐1, a novel C‐MYC binding protein that stimulates transcription activity of C‐MYC
Taira, T., Maëda, J., Onishi, T., Kitaura, H., Yoshida, S., Kato, H., Ikeda, M., Tamai, K., Iguchi‐Ariga, S. M. M., & Ariga, H. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00206.x · Cited by 92
Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome
Toro, J. R., Stoll, H. L., Stomper, P. C., & Oseroff, A. R. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)70212-3 · Cited by 89
Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases.
BASARAB, T., Fraser-Andrews, E. A., Orchard, G. E., Whittaker, S. J., & Russel-Jones, R. (1998) · PubMed · Cited by 88
Guttate Parapsoriasis/Digitate Dermatosis (Small Plaque Parapsoriasis) Is Mycosis Fungoides
King‐Ismael, D., & Ackerman, A. B. (1992) · American Journal of Dermatopathology · doi:10.1097/00000372-199212000-00005 · Cited by 80
Weinstock, M. A., & Horm, J. W. (1988) · Cancer · Cited by 78
Rappl, G., Muche, J. M., Abken, H., Sterry, W., Tilgen, W., Ugurel, S., & Reinhold, U. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.110900 · Cited by 74
Capocasale, R. J., Lamb, R. J., Vonderheid, E. C., Fox, F. E., Rook, A. H., Nowell, P. C., & Moore, J. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5501 · Cited by 64
Antigen‐presenting cell‐derived signals determine expression levels of CD70 on‘qc primed T cells
Lens, S. M. A., Baars, P. A., Hooibrink, B., van Oers, M. H. J., & van Lier, R. A. W. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00134.x · Cited by 57
A Membrane-bound Fas Decoy Receptor Expressed by Human Thymocytes
Jenkins, M., Keir, M. E., & McCune, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7988 · Cited by 45
BCL-X and the Apoptotic Machinery of Lymphoma Cells
Xerrp, L., Hassoun, J., Devilard, É., Birnbaum, D., & Birg, F. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809058352 · Cited by 34
Interleukin-7 receptor expression in cutaneous T-cell lymphomas
Bagot, M., Charue, D., Boulland, M., Gaulard, P., Revuz, J. E., Schmitt, C., & Wechsler, J. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb03833.x · Cited by 33
Brito-Babapulle, V., Hamoudi, R., Matutes, E., Watson, S., Kaczmarek, P. A., Maljaie, H., & Catovsky, D. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02174.x · Cited by 31
Willers, J., Häffner, A. C., Zepter, K., Storz, M., Urosevic, M., Burg, G., & Dummer, R. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01339.x · Cited by 22
Activity of proximal promoter of the human β1-integrin gene was increased in Sézary syndrome
Paulin, Y., Boukhelifa, M., Derappe, C., Giner, M., Font, J., & Aubery, M. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00149-1 · Cited by 6
Cited by
WHO-EORTC classification for cutaneous lymphomas
Willemze, R. (2005) · Blood · doi:10.1182/blood-2004-09-3502 · Cited by 3,803
Self-citationAgar, N. S., Wedgeworth, E., Crichton, S., Mitchell, T. J., Cox, M., Ferreira, S., Robson, A., Calonje, E., Stefanato, C. M., Wain, E. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.7665 · Cited by 853
Bekkenk, M. W., Geelen, F. A. M. J., Vader, P. C. V. V., Heule, F., Geerts, M.-L., van Vloten, W. A., Meijer, C. J. L. M., & Willemze, R. (2000) · Blood · doi:10.1182/blood.v95.12.3653 · Cited by 800
Self-citationKim, Y. H., Liu, H. L., Mraz-Gernhard, S., Varghese, A., & Hoppe, R. T. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.857 · Cited by 653
Scarisbrick, J. J., Prince, H. M., Vermeer, M. H., Quaglino, P., Horwitz, S., Porcu, P., Stadler, R., Wood, G. S., Beylot-Barry, M., Pham-Ledard, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.7142 · Cited by 430
Self-citation
Metadata
- Authors
- van Doorn, R., Van Haselen, C. W., van Voorst Vader, P. C., Geerts, M.-L., Heule, F., de Rie, M., Steijlen, P. M., Dekker, S. K., van Vloten, W. A., & Willemze, R.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2000-04-01
- Volume
- 136
- Issue
- 4
- Pages
- 504-10
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2146015805
- Cited by
- 367
- References
- 53
- FWCI
- 13.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.